Does Mereo BioPharma Group plc - ADR (MREO) Have What it Takes to be in Your Portfolio Thursday?

Mereo BioPharma Group plc - ADR (MREO) is around the top of the Biotechnology industry according to InvestorsObserver. MREO received an overall rating of 82, which means that it scores higher than 82 percent of all stocks. Mereo BioPharma Group plc - ADR also achieved a score of 98 in the Biotechnology industry, putting it above 98 percent of Biotechnology stocks. Biotechnology is ranked 76 out of the 148 industries.

MREO has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on MREO!

See Full MREO Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Mereo BioPharma Group plc - ADR Stock Today?

Mereo BioPharma Group plc - ADR (MREO) stock is down -1.49% while the S&P 500 is up 0.61% as of 2:05 PM on Thursday, Sep 28. MREO is lower by -$0.02 from the previous closing price of $1.35 on volume of 315,536 shares. Over the past year the S&P 500 is higher by 15.63% while MREO is up 49.44%. MREO lost -$0.34 per share the over the last 12 months. Click Here to get the full Stock Report for Mereo BioPharma Group plc - ADR stock.